Filtered By:
Specialty: Gastroenterology
Countries: China Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 309 results found since Jan 2013.
Research landscape on COVID-19 and liver dysfunction: A bibliometric analysis
CONCLUSION: This bibliometric study provides a comprehensive overview of liver-related publications in COVID-19 research over the past 3 years. This study highlights the significant contributions of high-income nations, particularly the United States, China, and Italy, to the production of liver-related scholarly literature in this field. Most of the articles focused on liver dysfunction in patients with COVID-19 and the implications of the virus for gastroenterologists and hepatologists.PMID:37545639 | PMC:PMC10401660 | DOI:10.3748/wjg.v29.i27.4356
Source: World Journal of Gastroenterology : WJG - August 7, 2023 Category: Gastroenterology Authors: Sa'ed H Zyoud Source Type: research
Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
Little is known about the risks of drug-induced liver injury potentially associated with the use of molnupiravir or ritonavir-boosted nirmatrelvir in a real-world setting until the recently reported work by Wong et al.1 In their study, they analyzed retrospectively the data from 13,041 molnupiravir users and 4408 ritonavir-boosted nirmatrelvir users vs 165,592 molnupiravir and nirmatrelvir nonusers in Hong Kong, China between January 1, 2022 and March 31, 2022 and concluded subsequently that both molnupiravi r and ritonavir-boosted nirmatrelvir were not associated with a higher risk of drug-induced liver injury as compared with nonusers.
Source: Gastroenterology - February 17, 2023 Category: Gastroenterology Authors: Guo-Fu Li, Guo Yu Tags: Correspondence Source Type: research
COVID-19 and liver injury: An ongoing challenge
World J Gastroenterol. 2023 Jan 14;29(2):257-271. doi: 10.3748/wjg.v29.i2.257.ABSTRACTThe new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide, causing coronavirus disease 2019 (COVID-19) pandemic. Although COVID-19 is presented, usually, with typical respiratory symptoms (i.e., dyspnea, cough) and fever, extrapulmonary manifestations are also encountered. Liver injury is a common feature in patients with COVID-19 and ranges from mild and temporary elevation of liver enzymes to severe liver injury and, even, acu...
Source: World Journal of Gastroenterology : WJG - January 23, 2023 Category: Gastroenterology Authors: Ioanna Papagiouvanni Serafeim-Chrysovalantis Kotoulas Athanasia Pataka Dionisios G Spyratos Konstantinos Porpodis Afroditi K Boutou Georgios Papagiouvannis Ioanna Grigoriou Christos Vettas Ioannis Goulis Source Type: research
